Advanced
  Home Compare Reports

Comparison with Similar Reports

Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services) Application (Cell Biology, Drug Discovery) Technology (Time-lapse M...

by Product (Instruments, Consumables, Software, Services) Application (Cell Biology, Drug Discovery) Technology (Time-lapse Microscopy, FRET) End User (Contract Research Organization, Research Institutes)

Publisher:        MarketsandMarkets

# of Pages:        206

Rating: 

1 User License $4,950

Publication Date:  October, 2020

Price:       $4,950 / User License




TABLE OF CONTENTS

 

1              INTRODUCTION                28

1.1          OBJECTIVES OF THE STUDY          28

1.2          MARKET DEFINITION      28

1.2.1      INCLUSIONS & EXCLUSIONS        29

1.3          MARKET SCOPE                29

1.3.1      MARKETS COVERED        29

1.3.2      YEARS CONSIDERED FOR THE STUDY        30

1.4          CURRENCY          30

1.5          LIMITATIONS     30

1.6          STAKEHOLDERS 30

1.7          SUMMARY OF CHANGES              31

2              RESEARCH METHODOLOGY         32

2.1          RESEARCH DATA               32

FIGURE 1             RESEARCH DESIGN          32

2.1.1      SECONDARY DATA           33

2.1.1.1   Key data from secondary sources             33

2.1.2      PRIMARY DATA 34

FIGURE 2             PRIMARY SOURCES         34

2.1.2.1   Key data from primary sources  35

FIGURE 3             BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION           35

2.2          MARKET SIZE ESTIMATION          36

FIGURE 4             MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS  36

FIGURE 5             MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (ILLUSTRATIVE EXAMPLE)             36

FIGURE 6             TOP-DOWN APPROACH                38

2.3          MARKET BREAKDOWN AND DATA TRIANGULATION        39

FIGURE 7             DATA TRIANGULATION METHODOLOGY               39

2.4          ASSUMPTIONS FOR THE STUDY 40

2.5          COVID-19 HEALTH ASSESSMENT                40

2.6          COVID-19 ECONOMIC ASSESSMENT        40

2.7          ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO          41

FIGURE 8             CRITERIA IMPACTING THE GLOBAL ECONOMY    41

FIGURE 9             SCENARIOS OF RECOVERY FROM COVID-19 IN THE GLOBAL ECONOMY   42

2.8          ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO OF THE LIVE CELL IMAGING MARKET                43

 

3              EXECUTIVE SUMMARY  44

TABLE 1                LIVE CELL IMAGING MARKET SNAPSHOT, 2020 VS. 2025 44

FIGURE 10           LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,

2020 VS. 2025 (USD MILLION)     45

FIGURE 11           LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,

2020 VS. 2025 (USD MILLION)     46

FIGURE 12           LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,

2020 VS. 2025 (USD MILLION)     47

FIGURE 13           LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2020 VS. 2025 (USD MILLION)     48

FIGURE 14           LIVE CELL IMAGING MARKET, BY APPLICATION,

2020 VS. 2025 (USD MILLION)     49

FIGURE 15           LIVE CELL IMAGING MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)            49

FIGURE 16           GEOGRAPHICAL SNAPSHOT OF THE LIVE CELL IMAGING MARKET              50

4              PREMIUM INSIGHTS       52

4.1          LIVE CELL IMAGING MARKET OVERVIEW               52

FIGURE 17           GROWING ADOPTION OF HIGH-CONTENT SCREENING TECHNIQUES AND RISING INCIDENCE OF CANCER ARE KEY FACTORS DRIVING MARKET GROWTH   52

4.2          APAC: LIVE CELL IMAGING MARKET, BY APPLICATION (2019)       53

FIGURE 18           CELL BIOLOGY APPLICATIONS COMMANDED THE LARGEST SHARE OF THE APAC LIVE CELL IMAGING MARKET IN 2019               53

4.3          LIVE CELL IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES  54

FIGURE 19           CHINA IS THE FASTEST-GROWING MARKET FOR LIVE CELL IMAGING        54

4.4          REGIONAL MIX: LIVE CELL IMAGING MARKET     55

FIGURE 20           ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD           55

4.5          LIVE CELL IMAGING MARKET: DEVELOPED VS. DEVELOPING MARKETS    56

FIGURE 21           DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD  56

5              MARKET OVERVIEW       57

5.1          INTRODUCTION                57

5.2          MARKET DYNAMICS       57

TABLE 2                MARKET DYNAMICS: IMPACT ANALYSIS                57

5.2.1      DRIVERS               58

5.2.1.1   Growing adoption of high-content screening techniques in drug discovery           58

5.2.1.2   Rising incidence of cancer            58

FIGURE 22           GLOBAL CANCER INCIDENCE, 2008–2030               59

TABLE 3                GLOBAL CANCER INCIDENCE, BY REGION/COUNTRY, 2018 VS. 2030          59

5.2.1.3   Growing availability of research funds    59

5.2.1.4   Rising government funding in regenerative medicine research   60

TABLE 4                TOTAL FUNDING, BY SOURCE TYPE, 2016–2019 (USD MILLION)   60

5.2.2      RESTRAINTS       61

5.2.2.1   High cost of high-content screening systems       61

5.2.3      OPPORTUNITIES               61

5.2.3.1   Emerging markets           61

5.2.3.2   Applications of HCS in personalized medicine      62

5.2.4      CHALLENGES      62

5.2.4.1   Maintaining cell viability and the cellular environment in cell cultures       62

5.2.4.2   Dearth of skilled professionals   62

5.3          COVID-19 IMPACT ON THE LIVE CELL IMAGING MARKET                63

6              INDUSTRY INSIGHTS       64

6.1          INTRODUCTION                64

6.2          INDUSTRY TRENDS          64

6.2.1      RISING FOCUS OF MARKET PLAYERS ON ADVANCED PRODUCT LAUNCHES           64

6.2.2      GROWING ADOPTION OF LABEL-FREE TECHNOLOGIES   65

6.3          SUPPLY CHAIN ANALYSIS              65

FIGURE 23           SUPPLY CHAIN ANALYSIS: LIVE CELL IMAGING MARKET 65

6.4          VALUE CHAIN ANALYSIS               66

FIGURE 24           LIVE CELL IMAGING MARKET: VALUE CHAIN ANALYSIS   67

7              LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE    68

7.1          INTRODUCTION                69

TABLE 5                LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           69

7.2          IMPACT OF COVID-19 ON THE LIVE CELL IMAGING PRODUCT & SERVICE MARKET              69

7.3          INSTRUMENTS  69

TABLE 6                LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           70

TABLE 7                LIVE CELL IMAGING INSTRUMENTS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           70

7.3.1      MICROSCOPES  71

7.3.1.1   Broad applications and emerging technologies have resulted in the growing demand for microscopes     71

TABLE 8                CONVENTIONAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS         71

TABLE 9                CONFOCAL MICROSCOPES OFFERED BY KEY MARKET PLAYERS    72

TABLE 10              FLUORESCENCE MICROSCOPES OFFERED BY KEY MARKET PLAYERS           73

TABLE 11              LIVE CELL IMAGING MICROSCOPES MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           74

TABLE 12              LIVE CELL IMAGING MICROSCOPES MARKET, BY REGION,

2018–2025 (UNITS)          75

7.3.2      STANDALONE SYSTEMS 75

7.3.2.1   Standalone systems provide in-depth image analysis of live cells at a faster rate—a key factor driving market growth 75

TABLE 13              STANDALONE SYSTEMS OFFERED BY KEY MARKET PLAYERS          75

TABLE 14              LIVE CELL IMAGING STANDALONE SYSTEMS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           76

TABLE 15              LIVE CELL IMAGING STANDALONE SYSTEMS MARKET, BY REGION,

2018–2025 (UNITS)          76

7.3.3      CELL ANALYZERS               77

7.3.3.1   Players offer a wide range of cell analyzers to satisfy end-user demands               77

TABLE 16              CELL ANALYZERS OFFERED BY KEY MARKET PLAYERS        77

TABLE 17              LIVE CELL IMAGING CELL ANALYZERS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           78

7.3.4      ACCESSORIES     78

7.3.4.1   Accessories find wide use in live cell image analysis          78

TABLE 18              ACCESSORIES OFFERED BY KEY MARKET PLAYERS              79

TABLE 19              LIVE CELL IMAGING ACCESSORIES MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           80

7.4          CONSUMABLES                80

TABLE 20              LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,

2018–2025 (USD MILLION)           81

TABLE 21              LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           81

7.4.1      REAGENTS          82

7.4.1.1   Reagents have widespread usage in life sciences due to their application in various research activities    82

TABLE 22              REAGENTS OFFERED BY KEY MARKET PLAYERS    82

TABLE 23              LIVE CELL IMAGING REAGENTS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           83

7.4.2      ASSAY KITS         84

7.4.2.1   Repeat purchase of assay kits—a key driver for market growth  84

TABLE 24              ASSAY KITS OFFERED BY KEY MARKET PLAYERS   84

TABLE 25              LIVE CELL IMAGING ASSAY KITS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           84

7.4.3      MEDIA  85

7.4.3.1   Development of new and advanced technologies has resulted in an increased demand for high-quality media in biomedical research and processing        85

TABLE 26              MEDIA OFFERED BY KEY MARKET PLAYERS            85

TABLE 27              LIVE CELL IMAGING MEDIA MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           85

7.4.4      OTHER CONSUMABLES  86

TABLE 28              OTHER CONSUMABLES OFFERED BY KEY MARKET PLAYERS           86

TABLE 29              OTHER LIVE CELL IMAGING CONSUMABLES MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           87

7.5          SOFTWARE         87

7.5.1      TECHNOLOGICAL ADVANCEMENTS IN IMAGE ACQUISITION—

A KEY DRIVER FOR MARKET GROWTH     87

TABLE 30              SOFTWARE OFFERED BY KEY MARKET PLAYERS   88

TABLE 31              LIVE CELL IMAGING SOFTWARE MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           89

7.6          SERVICES             89

7.6.1      AVAILABILITY OF A WIDE RANGE OF SERVICES AND GROWING NUMBER OF INITIATIVES BY KEY PLAYERS TO DRIVE THE SERVICES MARKET  89

TABLE 32              SERVICES OFFERED BY KEY MARKET PLAYERS       90

TABLE 33              LIVE CELL IMAGING SERVICES MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           90

8              LIVE CELL IMAGING MARKET, BY APPLICATION  91

8.1          INTRODUCTION                92

TABLE 34              LIVE CELL IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)           92

8.2          IMPACT OF COVID-19 ON THE LIVE CELL IMAGING APPLICATIONS MARKET          92

8.3          CELL BIOLOGY    93

8.3.1      INCREASING PREVALENCE OF CANCER TO DRIVE GROWTH IN THE CELL BIOLOGY APPLICATION SEGMENT             93

TABLE 35              LIVE CELL IMAGING MARKET FOR CELL BIOLOGY, BY COUNTRY,

2018–2025 (USD MILLION)           93

8.4          STEM CELLS        94

8.4.1      IMPORTANCE OF STEM CELL RESEARCH HAS BOOSTED INVESTMENTS IN THIS AREA         94

TABLE 36              LIVE CELL IMAGING MARKET FOR STEM CELLS, BY COUNTRY,

2018–2025 (USD MILLION)           94

8.5          DEVELOPMENTAL BIOLOGY         95

8.5.1      GROWING RESEARCH IN DEVELOPMENTAL BIOLOGY—A KEY DRIVER FOR MARKET GROWTH       95

TABLE 37              LIVE CELL IMAGING MARKET FOR DEVELOPMENTAL BIOLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 95

8.6          DRUG DISCOVERY            96

8.6.1      USE OF HCS CELL-BASED ASSAYS HAS GROWN IN DRUG DEVELOPMENT STUDIES               96

TABLE 38              LIVE CELL IMAGING MARKET FOR DRUG DISCOVERY, BY COUNTRY,

2018–2025 (USD MILLION)           96

9              LIVE CELL IMAGING MARKET, BY TECHNOLOGY  97

9.1          INTRODUCTION                98

TABLE 39              LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)          98

9.2          TIME-LAPSE MICROSCOPY           98

9.2.1      GROWING NUMBER OF CELL-BASED RESEARCH ACTIVITIES WILL DRIVE THE DEMAND FOR TIME-LAPSE MICROSCOPY    98

TABLE 40              LIVE CELL IMAGING MARKET FOR TIME-LAPSE MICROSCOPY, BY COUNTRY, 2018–2025 (USD MILLION)   99

9.3          FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) 99

9.3.1      GROWING ADVANCEMENTS IN FLUORESCENT MATERIALS AND PROBES WILL INCREASE THE ADOPTION OF FRET TECHNOLOGY    99

TABLE 41              LIVE CELL IMAGING MARKET FOR FLUORESCENCE RESONANCE ENERGY TRANSFER, BY COUNTRY, 2018–2025 (USD MILLION)       100

9.4          FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING (FRAP)      100

9.4.1      ADVANCEMENTS IN CONFOCAL MICROSCOPY WILL SUPPORT THE MARKET GROWTH FOR FRAP                100

TABLE 42              LIVE CELL IMAGING MARKET FOR FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING, BY COUNTRY, 2018–2025 (USD MILLION)           101

9.5          HIGH-CONTENT SCREENING (HCS)           101

9.5.1      INCREASING DRUG DISCOVERY RESEARCH TO DRIVE THE GROWTH OF THIS MARKET       101

TABLE 43              LIVE CELL IMAGING MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2018–2025 (USD MILLION)                102

9.6          OTHER TECHNOLOGIES  102

TABLE 44              LIVE CELL IMAGING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018–2025 (USD MILLION)          103

10           LIVE CELL IMAGING MARKET, BY END USER         104

10.1        INTRODUCTION                105

TABLE 45              LIVE CELL IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)  105

10.2        IMPACT OF COVID-19 ON THE LIVE CELL IMAGING END-USER MARKET   105

10.3        PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES       105

10.3.1    INCREASING R&D ACTIVITIES AND THE PATENT CLIFF OF VARIOUS BLOCKBUSTER DRUGS TO INCREASE THE DEMAND FOR LIVE CELL IMAGING PRODUCTS AMONG PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES       105

TABLE 46              LIVE CELL IMAGING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)       106

10.4        ACADEMIC & RESEARCH INSTITUTES       106

10.4.1    RISING FOCUS OF THESE END USERS ON STRENGTHENING THEIR OWN DRUG DISCOVERY RESEARCH PROGRAMS TO DRIVE MARKET GROWTH             106

TABLE 47              LIVE CELL IMAGING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,

BY COUNTRY, 2018–2025 (USD MILLION)               107

10.5        CONTRACT RESEARCH ORGANIZATIONS                108

10.5.1    GROWING OUTSOURCING OF R&D ACTIVITIES BY PHARMACEUTICAL COMPANIES TO DRIVE THE DEMAND FOR LIVE CELL IMAGING SYSTEMS AMONG CONTRACT RESEARCH ORGANIZATIONS           108

TABLE 48              LIVE CELL IMAGING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS,

BY COUNTRY, 2018–2025 (USD MILLION)               108

11           LIVE CELL IMAGING MARKET, BY REGION             109

11.1        INTRODUCTION                110

11.2        COVID-19 IMPACT ON THE LIVE CELL IMAGING MARKET                110

TABLE 49              LIVE CELL IMAGING MARKET, BY REGION, 2018–2025 (USD MILLION)      111

11.3        NORTH AMERICA             111

FIGURE 25           NORTH AMERICA: LIVE CELL IMAGING MARKET SNAPSHOT         112

TABLE 50              NORTH AMERICA: LIVE CELL IMAGING MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           113

TABLE 51              NORTH AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)       113

TABLE 52              NORTH AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE, 2018–2025 (USD MILLION)        113

TABLE 53              NORTH AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)       114

TABLE 54              NORTH AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           114

TABLE 55              NORTH AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           115

TABLE 56              NORTH AMERICA: LIVE CELL IMAGING MARKET, BY END USER,

2018–2025 (USD MILLION)           115

11.3.1    US          115

11.3.1.1                The US dominates the North American live cell imaging market primarily due to the strong trend of pharmaceutical & biotechnology research and the high burden of cancer              115

TABLE 57              US: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           116

TABLE 58              US: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           117

TABLE 59              US: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,

2018–2025 (USD MILLION)           117

TABLE 60              US: LIVE CELL IMAGING MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           117

TABLE 61              US: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           118

TABLE 62              US: LIVE CELL IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)          118

11.3.2    CANADA              118

11.3.2.1                Government initiatives to promote research and the need to combat cancer are the key factors driving the growth of the live cell imaging market in Canada               118

TABLE 63              CANADA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           119

TABLE 64              CANADA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           120

TABLE 65              CANADA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,

2018–2025 (USD MILLION)           120

TABLE 66              CANADA: LIVE CELL IMAGING MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           120

TABLE 67              CANADA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           121

TABLE 68              CANADA: LIVE CELL IMAGING MARKET, BY END USER,

2018–2025 (USD MILLION)           121

11.4        EUROPE               121

TABLE 69              EUROPE: LIVE CELL IMAGING MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           122

TABLE 70              EUROPE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           122

TABLE 71              EUROPE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           123

TABLE 72              EUROPE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,

2018–2025 (USD MILLION)           123

TABLE 73              EUROPE: LIVE CELL IMAGING MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           123

TABLE 74              EUROPE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           124

TABLE 75              EUROPE: LIVE CELL IMAGING MARKET, BY END USER,

2018–2025 (USD MILLION)           124

11.4.1    GERMANY           124

11.4.1.1                Presence of a large number of academic research institutes and increasing R&D spending to drive the demand for live cell imaging in Germany               124

TABLE 76              GERMANY: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           125

TABLE 77              GERMANY: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           126

TABLE 78              GERMANY: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,

2018–2025 (USD MILLION)           126

TABLE 79              GERMANY: LIVE CELL IMAGING MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           126

TABLE 80              GERMANY: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           127

TABLE 81              GERMANY: LIVE CELL IMAGING MARKET, BY END USER,

2018–2025 (USD MILLION)           127

11.4.2    UK          127

11.4.2.1                High prevalence of cancer to drive market growth in the UK        127

TABLE 82              UK: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           128

TABLE 83              UK: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           128

TABLE 84              UK: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,

2018–2025 (USD MILLION)           129

TABLE 85              UK: LIVE CELL IMAGING MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           129

TABLE 86              UK: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           129

TABLE 87              UK: LIVE CELL IMAGING MARKET, BY END USER, 2018–2025 (USD MILLION)          130

11.4.3    FRANCE                130

11.4.3.1                Growth in the live cell imaging market in France can be attributed to the large pharmaceutical manufacturing industry and the high public expenditure on R&D               130

TABLE 88              FRANCE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           131

TABLE 89              FRANCE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           131

TABLE 90              FRANCE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,

2018–2025 (USD MILLION)           132

TABLE 91              FRANCE: LIVE CELL IMAGING MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           132

TABLE 92              FRANCE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           132

TABLE 93              FRANCE: LIVE CELL IMAGING MARKET, BY END USER,

2018–2025 (USD MILLION)           133

11.4.4    REST OF EUROPE (ROE) 133

TABLE 94              ROE: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           134

TABLE 95              ROE: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           134

TABLE 96              ROE: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,

2018–2025 (USD MILLION)           135

TABLE 97              ROE: LIVE CELL IMAGING MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           135

TABLE 98              ROE: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           135

TABLE 99              ROE: LIVE CELL IMAGING MARKET, BY END USER,

2018–2025 (USD MILLION)           136

11.5        ASIA PACIFIC     136

FIGURE 26           ASIA PACIFIC: LIVE CELL IMAGING MARKET SNAPSHOT  137

TABLE 100            ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           138

TABLE 101            ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           138

TABLE 102            ASIA PACIFIC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           138

TABLE 103            ASIA PACIFIC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,

2018–2025 (USD MILLION)           139

TABLE 104            ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           139

TABLE 105            ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           140

TABLE 106            ASIA PACIFIC: LIVE CELL IMAGING MARKET, BY END USER,

2018–2025 (USD MILLION)           140

11.5.1    CHINA   140

11.5.1.1                China to register the highest growth rate in the Asia Pacific live cell imaging market during the forecast period   140

TABLE 107            CHINA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           141

TABLE 108            CHINA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           141

TABLE 109            CHINA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,

2018–2025 (USD MILLION)           142

TABLE 110            CHINA: LIVE CELL IMAGING MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           142

TABLE 111            CHINA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           143

TABLE 112            CHINA: LIVE CELL IMAGING MARKET, BY END USER,

2018–2025 (USD MILLION)           143

11.5.2    JAPAN  143

11.5.2.1                Rising prominence of regenerative medicine research and an increasing number of researchers to support market growth in Japan                143

TABLE 113            JAPAN: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           144

TABLE 114            JAPAN: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           144

TABLE 115            JAPAN: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,

2018–2025 (USD MILLION)           145

TABLE 116            JAPAN: LIVE CELL IMAGING MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           145

TABLE 117            JAPAN: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           145

TABLE 118            JAPAN: LIVE CELL IMAGING MARKET, BY END USER,

2018–2025 (USD MILLION)           146

11.5.3    INDIA    146

11.5.3.1                Favorable changes in foreign direct investment (FDI) regulations in the pharmaceutical industry to drive market growth in India  146

TABLE 119            INDIA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           147

TABLE 120            INDIA: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           147

TABLE 121            INDIA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,

 2018–2025 (USD MILLION)          147

TABLE 122            INDIA: LIVE CELL IMAGING MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           148

TABLE 123            INDIA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           148

TABLE 124            INDIA: LIVE CELL IMAGING MARKET, BY END USER,

2018–2025 (USD MILLION)           148

11.5.4    REST OF ASIA PACIFIC (ROAPAC)              149

TABLE 125            ROAPAC: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE,

2018–2025 (USD MILLION)           150

TABLE 126            ROAPAC: LIVE CELL IMAGING INSTRUMENTS MARKET, BY TYPE,

2018–2025 (USD MILLION)           150

TABLE 127            ROAPAC: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE,

2018–2025 (USD MILLION)           150

TABLE 128            ROAPAC: LIVE CELL IMAGING MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           151

TABLE 129            ROAPAC: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           151

TABLE 130            ROAPAC: LIVE CELL IMAGING MARKET, BY END USER,

2018–2025 (USD MILLION)           151

11.6        LATIN AMERICA                152

11.6.1    MAJOR PLAYERS ESTABLISHING MANUFACTURING FACILITIES IN LATIN AMERICA TO LEVERAGE THE LOW LABOR COST—A KEY GROWTH DRIVER 152

TABLE 131            LATIN AMERICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)          153

TABLE 132            LATIN AMERICA: LIVE CELL IMAGING INSTRUMENTS MARKET,

BY TYPE, 2018–2025 (USD MILLION)         153

TABLE 133            LATIN AMERICA: LIVE CELL IMAGING CONSUMABLES MARKET, BY TYPE, 2018–2025 (USD MILLION)         153

TABLE 134            LATIN AMERICA: LIVE CELL IMAGING MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           154

TABLE 135            LATIN AMERICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY,

2018–2025 (USD MILLION)           154

TABLE 136            LATIN AMERICA: LIVE CELL IMAGING MARKET, BY END USER,

2018–2025 (USD MILLION)           155

11.7        MIDDLE EAST & AFRICA 155

11.7.1    SHORTAGE OF TRAINED PROFESSIONALS TO RESTRAIN THE GROWTH OF THE CELL ANALYSIS MARKET IN THE MIDDLE EAST & AFRICA 155

TABLE 137            MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY PRODUCT & SERVICE, 2018–2025 (USD MILLION)                156

TABLE 138            MIDDLE EAST & AFRICA: LIVE CELL IMAGING INSTRUMENTS MARKET,

BY TYPE, 2018–2025 (USD MILLION)         156

TABLE 139            MIDDLE EAST & AFRICA: LIVE CELL IMAGING CONSUMABLES MARKET,

BY TYPE, 2018–2025 (USD MILLION)         156

TABLE 140            MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY APPLICATION, 2018–2025 (USD MILLION)         157

TABLE 141            MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY TECHNOLOGY, 2018–2025 (USD MILLION)         157

TABLE 142            MIDDLE EAST & AFRICA: LIVE CELL IMAGING MARKET, BY END USER,

2018–2025 (USD MILLION)           158

12           COMPETITIVE LANDSCAPE           159

12.1        OVERVIEW          159

FIGURE 27           KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS FROM JANUARY 2018 TO SEPTEMBER 2020      159

12.2        COMPETITIVE SITUATION AND TRENDS 160

12.2.1    PRODUCT LAUNCHES     160

TABLE 143            PRODUCT LAUNCHES     160

12.2.2    PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 160

TABLE 144            PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 161

12.2.3    ACQUISITIONS  161

TABLE 145            ACQUISITIONS  162

12.2.4    EXPANSIONS     162

TABLE 146            KEY EXPANSIONS             162

13           COMPANY EVALUATION MATRIX AND COMPANY PROFILES        163

13.1        COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY              163

13.2        COMPETITIVE LEADERSHIP MAPPING     163

13.2.1    STARS   163

13.2.2    EMERGING LEADERS      163

13.2.3    PERVASIVE COMPANIES               164

13.2.4    EMERGING COMPANIES               164

FIGURE 28           LIVE CELL IMAGING MARKET: COMPETITIVE LEADERSHIP MAPPING (2019)           164

13.3        MARKET SHARE ANALYSIS            165

FIGURE 29           MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019                165

13.4        COMPANY PROFILES      168

(Business Overview, Products Offered, Recent Developments, MnM View)*

13.4.1    DANAHER CORPORATION            168

FIGURE 30           DANAHER CORPORATION: COMPANY SNAPSHOT (2019)               168

13.4.2    CARL ZEISS AG   172

FIGURE 31           CARL ZEISS AG: COMPANY SNAPSHOT (2019)      172

13.4.3    NIKON CORPORATION  175

FIGURE 32           NIKON CORPORATION: COMPANY SNAPSHOT (2019)     175

13.4.4    OLYMPUS CORPORATION            178

FIGURE 33           OLYMPUS CORPORATION: COMPANY SNAPSHOT (2019)               178

13.4.5    PERKINELMER INC.          181

FIGURE 34           PERKINELMER INC.: COMPANY SNAPSHOT (2019)             181

13.4.6    SARTORIUS AG 183

FIGURE 35           SARTORIUS AG: COMPANY SNAPSHOT (2019)    183

13.4.7    BIOTEK INSTRUMENTS, INC.       185

13.4.8    THERMO FISHER SCIENTIFIC        187

FIGURE 36           THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2019)           187

13.4.9    ETALUMA, INC. 189

13.4.10  CYTOSMART TECHNOLOGIES      191

13.4.11  NANOENTEK INC.            192

13.4.12  GE HEALTHCARE               193

FIGURE 37           GE HEALTHCARE: COMPANY SNAPSHOT (2019)  193

13.4.13  BRUKER CORPORATION                195

FIGURE 38           BRUKER CORPORATION: COMPANY SNAPSHOT (2019)   195

13.4.14  BECTON, DICKINSON AND COMPANY     197

FIGURE 39           BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)        197

13.4.15  MERCK KGAA    199

FIGURE 40           MERCK KGAA: COMPANY SNAPSHOT (2019)       199

13.4.16  KEYENCE CORPORATION              201

13.4.17  LOGOS BIOSYSTEMS (ALIGNED GENETICS INC.)  202

13.4.18  NANOLIVE SA    202

13.4.19  SONY BIOTECHNOLOGY INC.       203

13.4.20  PHASE FOCUS LTD.          203

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.

 

14           APPENDIX           204

14.1        INSIGHTS FROM INDUSTRY EXPERTS       204

14.2        DISCUSSION GUIDE        205

14.3        KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL   209

14.4        AVAILABLE CUSTOMIZATIONS   211

14.5        RELATED REPORTS           211

14.6        AUTHOR DETAILS             212

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127